Keyphrases
Additive Effect
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Diabetic Nephropathy
100%
Ticagrelor
100%
Dapagliflozin
100%
Inflammasome
45%
AMP-activated Protein Kinase
45%
NOD-like Receptor Protein 3 (NLRP3)
36%
Kinase Activation
18%
Cystatin C (Cys C)
18%
Albumin
9%
Insulin
9%
Fibrosis
9%
Quantitative PCR
9%
Protective Effect
9%
Immunoblotting
9%
Renal Cortex
9%
Diabetic Cardiomyopathy
9%
Inflammasome Activation
9%
Serum Creatinine
9%
AKT1
9%
Anti-inflammatory Effect
9%
Hematoxylin
9%
Collagen III
9%
Periodic acid-Schiff
9%
Collagen Type 1
9%
Eosin
9%
Urinary Albumin
9%
C-level
9%
Akt Activation
9%
Reduced Activation
9%
Plasma Creatinine
9%
Mesangial Matrix Index
9%
Pharmacology, Toxicology and Pharmaceutical Science
Diabetic Nephropathy
100%
Ticagrelor
100%
Dapagliflozin
100%
Maturity Onset Diabetes of the Young
100%
Inflammasome
54%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
45%
Nucleotide Binding Oligomerization Domain Like Receptor
36%
Creatinine
18%
Cystatin C
18%
Albumin
18%
Ob/Ob Mouse
18%
Enzyme-Linked Immunosorbent Assay
9%
Fibrosis
9%
Western Blot
9%
Diabetic Cardiomyopathy
9%
Collagen Type 3
9%
Antiinflammatory Activity
9%
Haematoxylin
9%
Eosin
9%
Collagen Type 1
9%
Periodic Acid
9%